Health Condition 1: N04- Nephrotic syndrome
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Sponsors
Dr Raakhi Tripathi
Eligibility
Inclusion criteria
Inclusion criteria: A) For Pediatric patients 1. Male or female patients with confirmed diagnosis of Nephrotic Syndrome attending Pediatric or Nephrology OPD. 2. Patients aged 2 years to 18 years. 3. Patients who have been on treatment for more than 1 month. B)For Adult patients 1. Male or female patients with confirmed diagnosis of Nephrotic Syndrome attending Nephrology OPD. 2. Patients aged 18 years to 60 years. 3. Patients who have been on treatment for more than 1 month.
Exclusion criteria
Exclusion criteria: A) For Pediatric patients 1. Parents/caregivers not willing to give informed consent 2. Patients (aged 7-18 years) not willing to give assent 3. Patients admitted in IPD and emergency departments B) For Adult patients 1. Patients not willing to give informed consent 2. Patients admitted in IPD and emergency departments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.The primary variable is percentage of patients stating ?Yes/No? for each item of the Drug Awareness Questionnaire. 2.Mean awareness score will be calculated 3. Mean Awareness Score will be correlated with demographic factors (Age, gender, occupation, education and socio-economic status as per Kuppuswamy scale) Timepoint: As this is a cross-sectional survey, outcomes will be assessed at end of study, i.e, 18 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate perceived Medication Adherence which will be assessed by the percentage of patients stating ?Yes/No? for each item of the Medication Adherence Questionnaire. For evaluating actual Medication Adherence, the percentage of Medication Adherence will be calculated using pill count method formula. Timepoint: As this is a cross-sectional survey, outcomes will be assessed at end of study, i.e, 18 months.;To study the pattern of drugs used in the treatment of Nephrotic SyndromeTimepoint: As this is a cross-sectional survey, outcomes will be assessed at end of study, i.e, 18 months;To evaluate the prescribed drug regimen as per the package insert of the prescribed drugs Timepoint: As this is a cross-sectional survey, outcomes will be assessed at end of study, i.e, 18 months | — |
Countries
India
Contacts
Public ContactDr Raakhi Tripathi
Seth GS Medical College and KEM Hospital
Outcome results
None listed